DexCom, Inc.
DXCM
$66.33
$0.711.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.51% | 11.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.51% | 11.69% | |||
| Cost of Revenue | 2.05% | 4.77% | |||
| Gross Profit | 6.18% | 16.94% | |||
| SG&A Expenses | 1.04% | 5.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.36% | 4.68% | |||
| Operating Income | 14.06% | 59.01% | |||
| Income Before Tax | 46.12% | 56.25% | |||
| Income Tax Expenses | 11.75% | 25.36% | |||
| Earnings from Continuing Operations | 57.84% | 70.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 57.84% | 70.59% | |||
| EBIT | 14.06% | 59.01% | |||
| EBITDA | 11.07% | 42.28% | |||
| EPS Basic | 58.22% | 70.17% | |||
| Normalized Basic EPS | 46.50% | 55.84% | |||
| EPS Diluted | 57.17% | 68.40% | |||
| Normalized Diluted EPS | 46.40% | 55.98% | |||
| Average Basic Shares Outstanding | -0.26% | 0.26% | |||
| Average Diluted Shares Outstanding | -0.20% | 0.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||